Wednesday, February 11, 2026 | 05:55 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Share Price

Know More
BSENSE

₹538.00 44.00 (8.91%)

04:01 PM, 10-Feb-2026

₹535.15 41.25 (8.35%)

03:47 PM, 10-Feb-2026

BSE : 531633

NSE : LINCOLN

Sector : Health care

ISIN Code : INE405C01035

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 10-Feb-2026 | 04:01 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

1,078

Traded Value (₹ Cr)

0.26

Volume (Shares)

4,852

Face Value (₹)

10

52-Week High (₹)

749.90

52-Week High Date

10-Feb-2025

52-Week Low (₹)

439.95

52-Week Low Date

28-Jan-2026

All Time High (₹)

975.00

All Time High Date

09-Dec-2024

All Time Low (₹)

8.05

All Time Low Date

12-Jun-2002

Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited promoted by Mahendra G Patel Rajnikant G Patel and Hasmukhbhai I Patel as a Partnership Firm in January 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is enga...
Read More

Market News

More

Lincoln Pharma. Announcement

Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December 2025 And Other Business if any.

Update on Credit Rating.

Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31 2025.

Intimation of Closure of Trading Window

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.

More

Lincoln Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,072

EPS - TTM (₹) [C]

39.94

P/E Ratio (X) [C]

13.40

Face Value (₹) 10
Latest Dividend (%)18.00
Latest Dividend Date 12-Sep-2025
Dividend Yield (%) 0.34
Book Value Share (₹) [C]357.35
P/B Ratio (₹) [C]1.50

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Motilal Oswal BSE Healthcare ETF 0.01 305 0.03
Bandhan BSE Healthcare Index Fund - Regular (G) 0.01 119 0.03
Bandhan BSE Healthcare Index Fund - Direct (G) 0.01 119 0.03

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

491.60

550.00

Week Low/High (₹)

452.90

550.00

Month Low/High (₹)

440.00

550.00

Year Low/High (₹)

440.00

755.00

All time Low/High (₹)

8.05

980.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week11.84%11.89%0.64%0.81%
1 Month9.81%9.93%0.83%0.98%
3 Month2.60%2.50%0.88%1.41%
6 Month-5.01%-4.84%5.53%6.45%
1 Year-24.72%-24.81%9.01%10.92%
3 Year62.86%62.46%38.88%45.24%

Company Info

Company Information

Chairman (Non-Executive) : Kishorbhai M Shah

Managing Director : Mahendra G Patel

Whole-time Director : Hasmukhbhai I Patel

Whole-time Director : Munjal Mahendrabhai Patel

Whole-time Director : Aashish R Patel

Independent Director : Saurin J Parikh

Non Executive Director : Rajnikant G Patel

Company Sec. & Compli. Officer : Trusha Shah

Independent Director : Seema Mehta

Independent Director : Nareshkumar Pirabhai Suthar

Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000

Email:cs@lincolnpharma.com; investor@lincolnpharma.com

URL:http://www.lincolnpharma.com

FAQs about Lincoln Pharmaceuticals Ltd

1. What's the Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price was Rs 538.00 at 04:01 PM IST on 10th Feb 2026. Lincoln Pharmaceuticals Ltd share price was up by 8.91% over the previous closing price of Rs 494.00. Lincoln Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Lincoln Pharmaceuticals Ltd share price moved up by 9.81% on BSE.
  • Last 3 Months: Lincoln Pharmaceuticals Ltd share price moved up by 2.60% on BSE.
  • Last 12 Months: Lincoln Pharmaceuticals Ltd share price moved down by 24.72% on BSE.
  • Last 3 Years: Lincoln Pharmaceuticals Ltd share price moved up by 62.86% on BSE.


2. How can I quickly analyse the performance of the Lincoln Pharmaceuticals Ltd stock?
The performance of the Lincoln Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 13.40
  • Price to book value ratio is 1.50
  • Dividend yield of 0.34
  • The EPS (trailing 12 months) of the Lincoln Pharmaceuticals Ltd stock is Rs 39.94


3. What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of Rs 1,078 crore.


4. What is Lincoln Pharmaceuticals Ltd's 52-week high/low share price?
The Lincoln Pharmaceuticals Ltd’s 52-week high share price is Rs 749.90 and 52-week low share price is Rs 439.95.


5. Is the Lincoln Pharmaceuticals Ltd profitable?
On a consolidated basis, Lincoln Pharmaceuticals Ltd reported a profit of Rs 19.98 crore on a total income of Rs 170.60 crore for the quarter ended 2025.


6. Which are Lincoln Pharmaceuticals Ltd’s peers in the Health care sector?
Lincoln Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Bajaj Healthcare, Kwality Pharma, Ind-Swift Labs., Lincoln Pharma., Venus Remedies, Sigachi Indust., Fredun Pharma.


7. Who owns how much in Lincoln Pharmaceuticals Ltd?
Key changes to the Lincoln Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Lincoln Pharmaceuticals Ltd has gone up to 49.78 per cent as of Dec 2025 from 49.78 per cent as of Mar 2025.